Literature DB >> 16731932

Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity.

Ning Zhi1, Ian P Mills, Jun Lu, Susan Wong, Claudia Filippone, Kevin E Brown.   

Abstract

In an attempt to experimentally define the roles of viral proteins encoded by the B19 genome in the viral life cycle, we utilized the B19 infectious clone constructed in our previous study to create two groups of B19 mutant genomes: (i) null mutants, in which either a translational initiation codon for each of these viral genes was substituted by a translational termination codon or a termination codon was inserted into the open reading frame by a frameshift; and (ii) a deletion mutant, in which half of the hairpin sequence was deleted at both the 5' and the 3' termini. The impact of these mutations on viral infectivity, DNA replication, capsid protein production, and distribution was systematically examined. Null mutants of the NS and VP1 proteins or deletion of the terminal hairpin sequence completely abolished the viral infectivity, whereas blocking expression of the 7.5-kDa protein or the putative protein X had no effect on infectivity in vitro. Blocking expression of the proline-rich 11-kDa protein significantly reduced B19 viral infectivity, and protein studies suggested that the expression of the 11-kDa protein was critical for VP2 capsid production and trafficking in infected cells. These findings suggest a previously unrecognized role for the 11-kDa protein, and together the results enhance our understanding of the key features of the B19 viral genome and proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16731932      PMCID: PMC1472615          DOI: 10.1128/JVI.02430-05

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Parvovirus-associated arthritis.

Authors:  M Matsumura
Journal:  Am J Med       Date:  2001-08-15       Impact factor: 4.965

2.  SAT: a late NS protein of porcine parvovirus.

Authors:  Zoltán Zádori; József Szelei; Peter Tijssen
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

3.  Comparison of major antigenic proteins of six strains of the human granulocytic ehrlichiosis agent by Western immunoblot analysis.

Authors:  N Zhi; Y Rikihisa; H Y Kim; G P Wormser; H W Horowitz
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

4.  Most of the VP1 unique region of B19 parvovirus is on the capsid surface.

Authors:  M Kawase; M Momoeda; N S Young; S Kajigaya
Journal:  Virology       Date:  1995-08-20       Impact factor: 3.616

5.  Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein.

Authors:  Jun Lu; Ning Zhi; Susan Wong; Kevin E Brown
Journal:  J Infect Dis       Date:  2006-01-19       Impact factor: 5.226

Review 6.  Parvovirus-associated arthritis.

Authors:  T L Moore
Journal:  Curr Opin Rheumatol       Date:  2000-07       Impact factor: 5.006

7.  A viral phospholipase A2 is required for parvovirus infectivity.

Authors:  Z Zádori; J Szelei; M C Lacoste; Y Li; S Gariépy; P Raymond; M Allaire; I R Nabi; P Tijssen
Journal:  Dev Cell       Date:  2001-08       Impact factor: 12.270

8.  Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells.

Authors:  S Moffatt; N Yaegashi; K Tada; N Tanaka; K Sugamura
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

9.  Establishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7.

Authors:  N Komatsu; M Yamamoto; H Fujita; A Miwa; K Hatake; T Endo; H Okano; T Katsube; Y Fukumaki; S Sassa
Journal:  Blood       Date:  1993-07-15       Impact factor: 22.113

10.  Congenital anaemia after transplacental B19 parvovirus infection.

Authors:  K E Brown; S W Green; J Antunez de Mayolo; J A Bellanti; S D Smith; T J Smith; N S Young
Journal:  Lancet       Date:  1994-04-09       Impact factor: 79.321

View more
  55 in total

1.  Human parvovirus B19 causes cell cycle arrest of human erythroid progenitors via deregulation of the E2F family of transcription factors.

Authors:  Zhihong Wan; Ning Zhi; Susan Wong; Keyvan Keyvanfar; Delong Liu; Nalini Raghavachari; Peter J Munson; Su Su; Daniela Malide; Sachiko Kajigaya; Neal S Young
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

2.  Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

Authors:  Anna Ekman; Kati Hokynar; Laura Kakkola; Kalle Kantola; Lea Hedman; Heidi Bondén; Matthias Gessner; Claudia Aberham; Päivi Norja; Simo Miettinen; Klaus Hedman; Maria Söderlund-Venermo
Journal:  J Virol       Date:  2007-04-04       Impact factor: 5.103

3.  Human B19 erythrovirus in vitro replication: what's new?

Authors:  Sylvie Pillet; Serge Fichelson; Frédéric Morinet; Neal S Young; Ning Zhi; Susan Wong
Journal:  J Virol       Date:  2008-09       Impact factor: 5.103

4.  Block to the production of full-length B19 virus transcripts by internal polyadenylation is overcome by replication of the viral genome.

Authors:  Wuxiang Guan; Fang Cheng; Yuko Yoto; Steve Kleiboeker; Susan Wong; Ning Zhi; David J Pintel; Jianming Qiu
Journal:  J Virol       Date:  2008-08-06       Impact factor: 5.103

5.  Parvovirus B19 - Revised.

Authors:  Johannes Blümel; Reinhard Burger; Christian Drosten; Albrecht Gröner; Lutz Gürtler; Margarethe Heiden; Martin Hildebrandt; Bernd Jansen; Thomas Montag-Lessing; Ruth Offergeld; Georg Pauli; Rainer Seitz; Uwe Schlenkrich; Volkmar Schottstedt; Johanna Strobel; Hannelore Willkommen; Carl-Heinz Wirsing von König
Journal:  Transfus Med Hemother       Date:  2010-11-17       Impact factor: 3.747

6.  Internal polyadenylation of parvoviral precursor mRNA limits progeny virus production.

Authors:  Qinfeng Huang; Xuefeng Deng; Sonja M Best; Marshall E Bloom; Yi Li; Jianming Qiu
Journal:  Virology       Date:  2012-02-21       Impact factor: 3.616

Review 7.  Parvovirus diversity and DNA damage responses.

Authors:  Susan F Cotmore; Peter Tattersall
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

8.  Human parvovirus B19 infection causes cell cycle arrest of human erythroid progenitors at late S phase that favors viral DNA replication.

Authors:  Yong Luo; Steve Kleiboeker; Xuefeng Deng; Jianming Qiu
Journal:  J Virol       Date:  2013-09-18       Impact factor: 5.103

9.  The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.

Authors:  Peng Xu; Aaron Yun Chen; Safder S Ganaie; Fang Cheng; Weiran Shen; Xiaomei Wang; Steve Kleiboeker; Yi Li; Jianming Qiu
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

10.  Parvovirus B19 genotype specific amino acid substitution in NS1 reduces the protein's cytotoxicity in culture.

Authors:  Violetta Kivovich; Leona Gilbert; Matti Vuento; Stanley J Naides
Journal:  Int J Med Sci       Date:  2010-05-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.